Home » Topics » Infection » HIV/AIDS

HIV/AIDS
RSS

Yisheng Biopharma to collaborate with The Scripps Research Institute in developing new AIDS vaccine

Nov. 15, 2016

VRC-01 only slightly delays HIV rebound in clinical studies

Nov. 11, 2016

TaiMed Biologics notifies Theratechnologies of preliminary results for phase III trial of ibalizumab

Nov. 11, 2016

ViiV Healthcare UK discloses antiviral agents

Nov. 10, 2016

Anti-alpha4beta7 MAb regimen leads to SIV suppression long after treatment in monkeys

Nov. 2, 2016

Gilead Sciences develops HIV integrase inhibitors

Oct. 26, 2016

Merck & Co. patents HIV integrase inhibitors

Oct. 11, 2016

Gilead opens phase II/III study of fixed-dose combination in young patients with HIV-1 infection

Oct. 7, 2016

Selexis expands collaboration with IAVI

Sep. 23, 2016

Aphios obtains funding from NIAID to develop cure for HIV/AIDS

Sep. 15, 2016

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 17, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...
Gene replacement rescues autism-related phenotypes in mice
BioWorld Science
Autism spectrum disorder (ASD), developmental epileptic encephalopathies and other neurodevelopmental disorders are driven by the disruption of genes regulating...